WEDINOS is a harm reduction project, and reflects trends in substance use. It is therefore important that samples are submitted with a completed 'Effects Record' and correct postcode information, including samples from outside of Wales. This does not affect your anonymity.
Any samples with web generated reference numbers (WXXXXXX) that do not have a completed 'Effects Record' or conflicting information re: correct postcode will not have their results published.
The sample profile generated as a result of analysis relates to only that sample and cannot be used to indicate the contents, profile or quality of a wider batch of the substance.
Health professionals: please refer to TOXBASE for current management advice
Following a review by the WEDINOS Programme Board, it has been decided that as of 25th July 2014, no further samples of Steroids and/or Image Enhancing drugs (SIEDs) will be tested by WEDINOS. For further information please click here.
Search
7037 results were found
4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 « Previous Next » 8 of 352Sample W009472
Date Received: 29/01/2019
Postcode: PR4
Purchase Intent: Ecstacy
Package Label: Not Stated
Sample Colour: Yellow
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Euphoria, Increased Energy, Increased Stamina, Empathy
Sample Upon Analysis (Major): MDMA
Sample Upon Analysis (Minor):
Sample W009473
Date Received: 29/01/2019
Postcode: PR4
Purchase Intent: Cocaine
Package Label: Not Stated
Sample Colour: White
Sample Form: Powder
Consumption Method: Snort / Sniff
Self-Reported Effects: Euphoria, Increased Energy, Enhanced Senses, Paranoia, Insomnia
Sample Upon Analysis (Major): Cocaine
Sample Upon Analysis (Minor):
Sample 000034832
Date Received: 29/01/2019
Postcode: CF11
Purchase Intent: Tramadol
Package Label: T100
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Relaxed, Irregular Heartbeat, Tiredness
Sample Upon Analysis (Major): No Active Component Identified
Sample Upon Analysis (Minor):
Sample W009443
The sample was not analysed for the following reason : Inappropriate submission
Sample W009436
Date Received: 29/01/2019
Postcode: TS18
Purchase Intent: Painkiller
Package Label: Not Stated
Sample Colour: Orange
Sample Form: Powder
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): No Active Component Identified
Sample Upon Analysis (Minor):
Sample W009444
The sample was not analysed for the following reason : Inconsistent effects form
Sample W009445
The sample was not analysed for the following reason : Inconsistent effects form
Sample W009458
Date Received: 29/01/2019
Postcode: LE56
Purchase Intent: E-liquid CBD
Package Label: Not Stated
Sample Colour: Colourless
Sample Form: Liquid
Consumption Method: Smoked
Self-Reported Effects: Relaxed, Paranoia, Confusion
Sample Upon Analysis (Major): 5F-ADB
Sample Upon Analysis (Minor):
Sample W009453
The sample was not analysed for the following reason : Incomplete effects form
Sample W009450
The sample was not analysed for the following reason : Inappropriate submission
Sample 000035552
Date Received: 29/01/2019
Postcode: LL11
Purchase Intent: Diazepam
Package Label: Diazepam
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Relaxed, Nausea, Depression
Sample Upon Analysis (Major): Diazepam
Sample Upon Analysis (Minor):
Sample W009438
Date Received: 29/01/2019
Postcode: G67
Purchase Intent: Ecstacy
Package Label: Not Stated
Sample Colour: Pink
Sample Form: Tablet
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): MDMA
Sample Upon Analysis (Minor):
Sample W009467
Date Received: 29/01/2019
Postcode: NP7
Purchase Intent: Diazepam 10mg
Package Label: Galenika Bensedin Diazepam 10mg
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Enhanced Senses, Relaxed
Sample Upon Analysis (Major): Diazepam
Sample Upon Analysis (Minor):
Sample W009464
Date Received: 29/01/2019
Postcode: CF14
Purchase Intent: Diazepam
Package Label: Diaepam 10mg
Sample Colour: Blue
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Relaxed
Sample Upon Analysis (Major): Diazepam
Sample Upon Analysis (Minor):
Sample W009459
The sample was not analysed for the following reason : Incomplete effects form
Sample W009457
Date Received: 28/01/2019
Postcode: BT12
Purchase Intent: Diazepam 10mg
Package Label: Not Stated
Sample Colour: Blue
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Increased Confidence, Relaxed, Memory Loss, Confusion
Sample Upon Analysis (Major): Alprazolam
Sample Upon Analysis (Minor):
Sample W009456
Date Received: 28/01/2019
Postcode: DD1
Purchase Intent: Amphetamine
Package Label: Not Stated
Sample Colour: White
Sample Form: Powder
Consumption Method: Oral
Self-Reported Effects: Increased Libido, Visual Hallucinations, Breathlesness, Chest Pains, Irregular Heartbeat, Nausea, Vomiting, Paranoia, Memory Loss, Confusion, Panic Attack, Loss of consciousness, Agitation, Insomnia, Depression, Suicidal Ideation
Sample Upon Analysis (Major): Caffeine
Sample Upon Analysis (Minor): Amphetamine
Sample W009460
Date Received: 28/01/2019
Postcode: B32
Purchase Intent: Xanax- Alprazolam 1mg
Package Label: Alpz-1 Alprazolam 1mg
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Euphoria, Empathy, Relaxed, Breathlesness, Memory Loss, Loss of consciousness
Sample Upon Analysis (Major): Alprazolam
Sample Upon Analysis (Minor):
Sample W009461
Date Received: 28/01/2019
Postcode: B32
Purchase Intent: Zolpidem 10mg
Package Label: Jpee drugs lypin-10-Zolpidem 10mg
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Euphoria, Empathy, Visual Hallucinations, Relaxed, Memory Loss, Confusion, Loss of consciousness
Sample Upon Analysis (Major): Zolpidem
Sample Upon Analysis (Minor):
Sample W009440
The sample was not analysed for the following reason : Incomplete effects form
Identified in Slovenia: • methyl 2‐{[1‐(5‐fluoropentyl)‐1H‐indol‐3‐yl]formamido}‐3‐phenylpropanoate (MPhP-2201)a synthetic cannabinoid receptor agonist
Global Drug Survey 2019: Global Drug Survey runs the largest drug survey in the world. Over half a million people have taken part in the last 5 surveys. Committed to helping people use drugs more safely regardless of the legal status of the drug and promoting honest conversation about drug use, GDS relies on the experience and expertise from people all over the world. Have you taken part this year #GDS19 https//www.globaldrugsurvey.com/GDS2019